The peptide INKKI showed antitumor activity on melanoma model, it
induced dose-response cytotoxicity selective for B16F10 melanoma cells
(IC50 1.7 μM) and did not present cytotoxic effects for FN1
fibroblast cells. INKKI-induced apoptosis detected trough of annexin
V/PI assay and it was accompanied with an increase of sub-G1 apoptotic
fractions and significant increase of caspase-3 cleavage. The
tumor-bearing mice treated with INKKI showed a significant reduction in
tumor volume of 72.62% and decreased of metastasis number loci. In
addition, INKKI caused a significant delay in tumor growth and prolonged
the tumor doubling time. Histological analysis revealed an increased of
necrosis areas and reduction of tumor cells in tumor treated with
INKKI, it was a many hallmark of its antitumor effects observed from in
vivo experiments. |